<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1335418" created="06/11/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1335418</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Activation of <term id="T1" lex="protein_kinase_C" sem="Protein_molecule">protein kinase C</term> and elevation of <term id="T2" lex="cAMP" sem="Nucleotide">cAMP</term> interact synergistically to raise <term id="T3" lex="c-Fos" sem="Protein_molecule">c-Fos</term> and <term id="T4" lex="AP-1" sem="Protein_molecule">AP-1</term> activity in Jurkat cells.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> protein kinase C and elevation of cAMP interact synergistically to raise c-Fos and AP-1 activity in Jurkat cells.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>Activation of protein kinase C and <clueType>elevation</clueType> <linkTheme>of</linkTheme> cAMP interact synergistically to raise c-Fos and AP-1 activity in Jurkat cells.</clue>
</event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="T3"/>
<cause idref="E1"/>
<cause idref="E2"/>
<clue>Activation of protein kinase C and elevation of cAMP <clueType>interact synergistically to raise</clueType> c-Fos and AP-1 activity <clueLoc>in Jurkat cells</clueLoc>.</clue>
</event>
<event id="E4">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<cause idref="E1"/>
<cause idref="E2"/>
<clue>Activation of protein kinase C and elevation of cAMP <clueType>interact synergistically to raise</clueType> c-Fos and AP-1 activity <clueLoc>in Jurkat cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We have earlier found that in Jurkat cells activation of <term id="T5" lex="protein_kinase_C" sem="Protein_molecule">protein kinase C</term> (<term id="T6" lex="PKC" sem="Protein_molecule">PKC</term>) enhances the cyclic adenosine monophosphate (<term id="T7" lex="cAMP" sem="Nucleotide">cAMP</term>) accumulation induced by <term id="A1" sem="Protein_molecule">adenosine receptor</term> stimulation or activation of <term id="T8" lex="Gs" sem="Protein_molecule">Gs</term>.</sentence>
<event id="E5">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<clue>We have earlier found that in Jurkat cells <clueType>activation</clueType> <linkTheme>of</linkTheme> protein kinase C (PKC) enhances the cyclic adenosine monophosphate (cAMP) accumulation induced by adenosine receptor stimulation or activation of Gs.</clue>
</event>
<event Source="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="E5"/>
<clue>We have <clueSource>earlier</clueSource> <clueKT>found</clueKT> that <clueLoc>in Jurkat cells</clueLoc> activation of protein kinase C (PKC) <clueType>enhances</clueType> the cyclic adenosine monophosphate (cAMP) accumulation induced by adenosine receptor stimulation or activation of Gs.</clue>
</event>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<clue>We have earlier found that in Jurkat cells activation of protein kinase C (PKC) enhances the cyclic adenosine monophosphate (cAMP) <clueType>accumulation</clueType> induced by adenosine receptor stimulation or activation of Gs.</clue>
</event>
<event id="E9">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="E11"/>
<clue>We have earlier found that in Jurkat cells activation of protein kinase C (PKC) enhances the cyclic adenosine monophosphate (cAMP) accumulation <clueType>induced</clueType> <linkCause>by</linkCause> adenosine receptor stimulation or activation of Gs.</clue>
</event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="E12"/>
<clue>We have earlier found that in Jurkat cells activation of protein kinase C (PKC) enhances the cyclic adenosine monophosphate (cAMP) accumulation <clueType>induced</clueType> <linkCause>by</linkCause> adenosine receptor stimulation or activation of Gs.</clue>
</event>
<event id="E11">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<clue>We have earlier found that in Jurkat cells activation of protein kinase C (PKC) enhances the cyclic adenosine monophosphate (cAMP) accumulation induced by adenosine receptor <clueType>stimulation</clueType> or activation of Gs.</clue>
</event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<clue>We have earlier found that in Jurkat cells activation of protein kinase C (PKC) enhances the cyclic adenosine monophosphate (cAMP) accumulation induced by adenosine receptor stimulation or <clueType>activation</clueType> <linkTheme>of</linkTheme> Gs.</clue>
</event>
<sentence id="S3">Here we have therefore examined the effect of the <term id="T9" lex="phorbol_ester" sem="Organic_compound_other">phorbol ester</term> <term id="T10" lex="PMA" sem="Organic_compound_other">PMA</term> (<term id="T11" lex="phorbol_12-myristate_13-acetate" sem="Organic_compound_other">phorbol 12-myristate 13-acetate</term>) which stimulates <term id="T12" lex="PKC" sem="Protein_molecule">PKC</term> and a combination of the <term id="T13" lex="adenosine_receptor_agonist" sem="Nucleotide"><term id="T14" lex="adenosine_receptor" sem="Protein_family_or_group">adenosine receptor</term> agonist</term> <term id="T15" lex="NECA" sem="Nucleotide">NECA</term> (<term id="T16" lex="5&apos;-(N-ethyl)-carboxamido_adenosine" sem="Nucleotide">5&apos;-(N-ethyl)-carboxamido adenosine</term>) and <term id="T17" lex="forskolin" sem="Organic_compound_other">forskolin</term> to raise <term id="T18" lex="cAMP" sem="Nucleotide">cAMP</term>, on the levels of <term id="T19" lex="c-Fos" sem="Protein_molecule">c-Fos</term> and <term id="T20" lex="Jun" sem="Protein_molecule">Jun</term> and on the binding and <term id="T21" lex="transcriptional_activity" sem="Other">transcriptional activity</term> of the <term id="T22" lex="transcription_factor" sem="Protein_domain_or_region">transcription factor</term>, <term id="T23" lex="activator_protein-1" sem="Protein_molecule">activator protein-1</term> (<term id="T24" lex="AP-1" sem="Protein_molecule">AP-1</term>).</sentence>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E17"/>
<cause idref="T10"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, <linkTheme>on</linkTheme> the levels of c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Investigation" id="E14" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E18"/>
<cause idref="T10"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, <linkTheme>on</linkTheme> the levels of c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Investigation" id="E15" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E19"/>
<cause idref="T10"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the levels of c-Fos and Jun and <linkTheme>on</linkTheme> the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Investigation" id="E22" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="T10"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the levels of c-Fos and Jun and <linkTheme>on</linkTheme> the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Investigation" id="E23" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E17"/>
<cause idref="E16"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, <linkTheme>on</linkTheme> the levels of c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Investigation" id="E24" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E18"/>
<cause idref="E16"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, <linkTheme>on</linkTheme> the levels of c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Investigation" id="E25" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E19"/>
<cause idref="T10"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the levels of c-Fos and Jun and <linkTheme>on</linkTheme> the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Investigation" id="E26" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="T10"/>
<clue>Here we have therefore <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the levels of c-Fos and Jun and <linkTheme>on</linkTheme> the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="T15"/>
<cause idref="T17"/>
<clue>Here we have therefore examined the effect of the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a <linkCause>combination of</linkCause> the <corefCause>adenosine receptor agonist</corefCause> NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to <clueType>raise</clueType> cAMP, on the levels of c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<clue>Here we have therefore examined the effect of the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the <clueType>levels</clueType> <linkTheme>of</linkTheme> c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="T20"/>
<clue>Here we have therefore examined the effect of the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the <clueType>levels</clueType> <linkTheme>of</linkTheme> c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Other" id="E19">
<type class="Binding"/>
<theme idref="T24"/>
<clue>Here we have therefore examined the effect of the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the levels of c-Fos and Jun and on the <clueType>binding</clueType> and transcriptional activity <linkTheme>of</linkTheme> the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<cause idref="T24"/>
<clue>Here we have therefore examined the effect of the phorbol ester PMA (phorbol 12-myristate 13-acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the levels of c-Fos and Jun and on the binding and <clueType>transcriptional activity</clueType> <linkCause>of</linkCause> the transcription factor, activator protein-1 (AP-1).</clue>
<comment>NO THEME</comment></event>
<event KT="Fact" id="E21">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T10"/>
<clue>Here we have therefore examined the effect of the phorbol ester PMA (phorbol 12-myristate 13-acetate) which <clueType>stimulates</clueType> PKC and a combination of the adenosine receptor agonist NECA (5&apos;-(N-ethyl)-carboxamido adenosine) and forskolin to raise cAMP, on the levels of c-Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein-1 (AP-1).</clue>
</event>
<sentence id="S4"><term id="T25" lex="PMA_treatment" sem="Other"><term id="T26" lex="PMA" sem="Organic_compound_other">PMA</term> treatment</term> caused a concentration- and time-dependent increase in both <cons id="T27" lex="(AND c-Fos_immunoreactivity Jun_immunoreactivity)" sem="(AND Other Other)"><frag id="F1"><term id="A2" sem="Protein_molecule">c-Fos</term></frag> and <frag id="F2"><term id="A3" sem="Protein_molecule">Jun</term></frag> <frag id="F3">immunoreactivity</frag></cons> in contrast to <term id="T28" lex="cAMP_elevation" sem="Other"><term id="T29" lex="cAMP" sem="Nucleotide">cAMP</term> elevation</term> that had only a slight effect.</sentence>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T26"/>
<clue>PMA treatment <clueType>caused</clueType> a concentration- and time-dependent <clueType>increase</clueType> <linkTheme>in</linkTheme> both c-Fos and Jun immunoreactivity in contrast to cAMP elevation that had only a slight effect.</clue>
</event>
<event id="E28">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T26"/>
<clue>PMA treatment <clueType>caused</clueType> a concentration- and time-dependent <clueType>increase</clueType> <linkTheme>in</linkTheme> both c-Fos and Jun immunoreactivity in contrast to cAMP elevation that had only a slight effect.</clue>
</event>
<event id="E29">
<type class="Regulation"/>
<theme idref="A2"/>
<clue>PMA treatment caused a concentration- and time-dependent increase in both c-Fos and Jun <clueType>immunoreactivity</clueType> in contrast to cAMP elevation that had only a slight effect.</clue>
</event>
<event id="E30">
<type class="Regulation"/>
<theme idref="A3"/>
<clue>PMA treatment caused a concentration- and time-dependent increase in both c-Fos and Jun <clueType>immunoreactivity</clueType> in contrast to cAMP elevation that had only a slight effect.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<clue>PMA treatment caused a concentration- and time-dependent increase in both c-Fos and Jun immunoreactivity in contrast to cAMP <clueType>elevation</clueType> that had only a slight effect.</clue>
</event>
<event Manner="Low" assertion="non-exist" id="E32">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="E31"/>
<clue>PMA treatment caused a concentration- and time-dependent increase <linkTheme>in</linkTheme> both c-Fos and Jun immunoreactivity in contrast to cAMP elevation that <clueType>had <clueManner>only a slight</clueManner> effect</clueType>.</clue>
</event>
<event Manner="Low" assertion="non-exist" id="E33">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T31"/>
<clue>PMA treatment caused a concentration- and time-dependent increase <linkTheme>in</linkTheme> both c-Fos and Jun immunoreactivity in contrast to cAMP elevation that <clueType>had <clueManner>only a slight</clueManner> effect</clueType>.</clue>
</event>
<sentence id="S5">Both <term id="T30" lex="PMA" sem="Organic_compound_other">PMA</term> and the combination of <term id="T31" lex="NECA" sem="Nucleotide">NECA</term> and <term id="T32" lex="forskolin" sem="Organic_compound_other">forskolin</term> acted together either to increase (<term id="T33" lex="c-Fos" sem="Protein_molecule">c-Fos</term>) or decrease (<term id="T34" lex="Jun" sem="Protein_molecule">Jun</term>) <term id="T35" lex="protein" sem="Protein_family_or_group">protein</term> levels as well as increasing <term id="T37" lex="AP-1" sem="Protein_molecule">AP-1</term> binding, as judged by <term id="T38" lex="gel-shift_assay" sem="Other">gel-shift assay</term>, and <term id="T39" lex="AP-1_transcriptional_activity" sem="Other"><term id="T40" lex="AP-1" sem="Protein_molecule">AP-1</term> transcriptional activity</term>.</sentence>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="T30"/>
<cause idref="T31"/>
<cause idref="T32"/>
<clue>Both PMA and the combination of NECA and forskolin <clueType>acted together</clueType> either to <clueType>increase</clueType> (c-Fos) or decrease (Jun) protein levels as well as increasing AP-1 binding, as judged by gel-shift assay, and AP-1 transcriptional activity.</clue>
<comment>CAUTION: three CAUSEs in combination</comment></event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<cause idref="T30"/>
<cause idref="T31"/>
<cause idref="T32"/>
<clue>Both PMA and the combination of NECA and forskolin <clueType>acted together</clueType> either to increase (c-Fos) or <clueType>decrease</clueType> (Jun) protein levels as well as increasing AP-1 binding, as judged by gel-shift assay, and AP-1 transcriptional activity.</clue>
<comment>CAUTION: three CAUSEs in combination</comment></event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="T30"/>
<cause idref="T31"/>
<cause idref="T32"/>
<clue>Both PMA and the combination of NECA and forskolin <clueType>acted together</clueType> either to increase (c-Fos) or decrease (Jun) protein levels as well as <clueType>increasing</clueType> AP-1 binding, as judged by gel-shift assay, and AP-1 transcriptional activity.</clue>
<comment>CAUTION: three CAUSEs in combination</comment></event>
<event id="E37">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="T30"/>
<cause idref="T31"/>
<cause idref="T32"/>
<clue>Both PMA and the combination of NECA and forskolin <clueType>acted together</clueType> either to increase (c-Fos) or decrease (Jun) protein levels as well as <clueType>increasing</clueType> AP-1 binding, as judged by gel-shift assay, and AP-1 transcriptional activity.</clue>
<comment>CAUTION: three CAUSEs in combination</comment></event>
<event id="E38">
<type class="Binding"/>
<theme idref="T37"/>
<clue>Both PMA and the combination of NECA and forskolin acted together either to increase (c-Fos) or decrease (Jun) protein levels as well as increasing AP-1 <clueType>binding</clueType>, <clueExperiment>as judged by gel-shift assay</clueExperiment>, and AP-1 transcriptional activity.</clue>
</event>
<event KT="Analysis" id="E39">
<type class="Positive_regulation"/>
<cause idref="T40"/>
<clue>Both PMA and the combination of NECA and forskolin acted together either to increase (c-Fos) or decrease (Jun) protein levels as well as increasing AP-1 binding, as <clueKT>judged</clueKT> by gel-shift assay, and AP-1 <clueType>transcriptional activity</clueType>.</clue>
<comment>NO THEME</comment></event>
<sentence id="S6">Furthermore there was a clear-cut synergy between the <term id="T41" lex="PKC_stimulator" sem="Organic_compound_other"><term id="T42" lex="PKC" sem="Protein_molecule">PKC</term> stimulator</term> and the <term id="T43" lex="cAMP_elevating_agent" sem="Organic_compound_other"><term id="T44" lex="cAMP" sem="Nucleotide">cAMP</term> elevating agents</term>.</sentence>
<event KT="Analysis" id="E40">
<type class="Correlation"/>
<theme idref="T41"/>
<theme idref="T43"/>
<clue>Furthermore there was a clear-cut <clueType><clueKT>synergy</clueKT></clueType> between the PKC stimulator and the cAMP elevating agents.</clue>
<comment>NER: T41 &amp; T43 sem mod, Other_name -&gt; Other_organic_compound</comment></event>
<sentence id="S7">The results demonstrate that the simultaneous activation of <term id="T45" lex="PKC" sem="Protein_molecule">PKC</term> and elevation of <term id="T46" lex="cAMP" sem="Nucleotide">cAMP</term> leads to an enhanced <term id="T47" lex="AP-1_transcriptional_activity" sem="Other"><term id="T48" lex="AP-1" sem="Protein_molecule">AP-1</term> transcriptional activity</term> in a <term id="T49" lex="T-leukemia_cell_line" sem="Cell_cultured">T-leukemia cell line</term>, suggesting that the previously observed interaction between the <term id="T50" lex="parallel_signal_transduction_pathway" sem="Other">parallel signal transduction pathways</term> may have functional consequences at the level of <term id="T51" lex="gene_transcription" sem="Other">gene transcription</term>.</sentence>
<event KT="Other" id="E41">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<clue>The results demonstrate that the simultaneous <clueType>activation</clueType> <linkTheme>of</linkTheme> PKC and elevation of cAMP leads to an enhanced AP-1 transcriptional activity in a T-leukemia cell line, suggesting that the previously observed interaction between the parallel signal transduction pathways may have functional consequences at the level of gene transcription.</clue>
</event>
<event KT="Other" id="E42">
<type class="Positive_regulation"/>
<theme idref="T46"/>
<clue>The results demonstrate that the simultaneous activation of PKC and <clueType>elevation</clueType> <linkTheme>of</linkTheme> cAMP leads to an enhanced AP-1 transcriptional activity in a T-leukemia cell line, suggesting that the previously observed interaction between the parallel signal transduction pathways may have functional consequences at the level of gene transcription.</clue>
</event>
<event KT="Analysis" id="E43">
<type class="Positive_regulation"/>
<theme idref="E44"/>
<cause idref="E41"/>
<cause idref="E42"/>
<clue>The results <clueKT>demonstrate</clueKT> that the <linkCause>simultaneous</linkCause> activation of PKC and elevation of cAMP <clueType>leads to an enhanced</clueType> AP-1 transcriptional activity in a T-leukemia cell line, suggesting that the previously observed interaction between the parallel signal transduction pathways may have functional consequences at the level of gene transcription.</clue>
</event>
<event KT="Other" id="E44">
<type class="Positive_regulation"/>
<cause idref="T48"/>
<clue>The results demonstrate that the simultaneous activation of PKC and elevation of cAMP leads to an enhanced AP-1 <clueType>transcriptional activity</clueType> <clueLoc>in a T-leukemia cell line</clueLoc>, suggesting that the previously observed interaction between the parallel signal transduction pathways may have functional consequences at the level of gene transcription.</clue>
<comment>NO THEME</comment></event>
<event Source="Other" id="E45">
<type class="Correlation"/>
<theme idref="T50"/>
<theme idref="T50"/>
<clue>The results demonstrate that the simultaneous activation of PKC and elevation of cAMP leads to an enhanced AP-1 transcriptional activity in a T-leukemia cell line, suggesting that the <clueSource>previously</clueSource> <clueKT>observed</clueKT> <clueType>interaction</clueType> <linkTheme>between</linkTheme> the parallel signal transduction pathways may have functional consequences at the level of gene transcription.</clue>
</event>
<event CL="L1" KT="Analysis" id="E46" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T51"/>
<cause idref="E45"/>
<clue>The results demonstrate that the simultaneous activation of PKC and elevation of cAMP leads to an enhanced AP-1 transcriptional activity in a T-leukemia cell line, <clueKT>suggesting</clueKT> that the previously observed interaction between the parallel signal transduction pathways <clueCL>may</clueCL> <clueType>have functional consequences</clueType> <linkTheme>at the level of</linkTheme> gene transcription.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
